Explainer: What happens in medical research before clinical trials begin?
When scientific advances burst into the news, such as a new medication to treat COVID-19 or a new concept like CRISPR for gene editing, people get a glimpse of how a scientific idea becomes a treatment or a tool.
But what's the full story?
Where did that idea come from? What happens in the research lab before clinical trials begin? How is scientific discovery transformed into a potential therapy that is ready to be tested in trials with human participants?
Get these answers and more by watching "The Discovery Science Journey" to learn in three minutes:
- How the process starts in the lab with discovery science, where researchers ask fundamental questions, such as, "What changes in a cell lead to cancer?"
- What happens next, as researchers team up to combine their knowledge and speed up the pace of discovery.
- How researchers navigate the regulations that safeguard the health of clinical trial participants and prepare a discovery to enter clinical trials.
The process of scientific discovery can be a long, exciting journey. But even when a discovery doesn't lead to a therapy — or doesn't lead there yet — research teams often uncover valuable information: new knowledge to advance the science of medicine.
When a discovery is ready, the next step is clinical trials. With human participants, clinical trials test whether a medical intervention, such as a drug, device or medical procedure, should move into patient care.
Watch this companion video, "The Clinical Trial Journey," to learn more about how clinical trials work.
— Caitlin Doran, May 16, 2022
Related Posts

A Mayo Clinic Center devoted to telomere biology disorders is helping to provide personalized care to patients with pulmonary fibrosis due to shortened telomeres.

In a study led by Mayo Clinic, researchers found invasive brain tumor margins of high-grade glioma with distinct genetic and molecular alterations that are detectable on clinical imaging with MRI and point to cancer recurrence. The findings suggest insights into improvements in diagnosis and potential treatments that could modify the course of the disease.

Vesna Garovic, M.D., Ph.D., has dedicated her career to studying preeclampsia. Her research could lead to new therapeutics and is already informing guidelines for women at risk.